Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

for
Solid Tumor, Adult, Solid Tumor, Melanoma, Basal Cell Cancer,
Location: Denver CO, Nashville TN
Sponsor: Rise Therapeutics LLC

Sex: All

Age: 18 - 70+

Code: NCT06398418

Phase 1, Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Nashville TN, Atlanta GA, St Louis MO, Durham NC,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase 1, Recruiting

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

for
Plasma Cell Myeloma Refractory
Location: Nashville TN, Knoxville TN, Greenville SC,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06356571

Phase 2, Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

for
Advanced Cancer, Advanced Solid Tumors
Location: Nashville TN, New Orleans LA, Orlando FL, Denver CO
Sponsor: Shanghai Allink Biotherapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06656390

Phase 1, Phase 2, Recruiting

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Nashville TN, Fairfax VA, Orlando FL, Dallas TX,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612189

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Nashville TN, Atlanta GA, Orlando FL, Buffalo NY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase 1, Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: Nashville TN, Indianapolis IN, St Louis MO, Columbus OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07046923

Phase 1, Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Nashville TN, Birmingham AL, St Louis MO,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase 1, Recruiting

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

for
Metastatic Uveal Melanoma, Cutaneous Melanoma,
Location: Nashville TN, Cincinnati OH, Durham NC, Houston TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT03947385

Phase 1, Phase 2, Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Nashville TN, Charlotte NC, Shreveport LA, Detroit MI,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase 2, Recruiting

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Nashville TN, Birmingham AL, Atlanta GA, Charlotte NC,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18+

Code: NCT07116616

Phase 1, Phase 2, Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Nashville TN, Myrtle Beach SC, Cleveland OH,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07140900

Phase 1, Recruiting

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

for
Advanced Solid Tumor
Location: Nashville TN, Scottsdale AZ
Sponsor: Strand Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07751042

Phase 1, Phase 2, Recruiting

A Study of CTD402 in T-ALL/LBL Patients

for
Acute Lymphocytic Leukemia Refractory, Lymphoma, Lymphoblastic
Location: Nashville TN, Chicago IL, Rochester MN, Houston TX,
Sponsor: Imviva Bio

Sex: All

Age: 1+

Code: NCT07070219

Phase 1, Phase 2, Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: Denver CO, Nashville TN, Cleveland OH, Jacksonville FL,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase 1, Recruiting

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

for
Metastatic Malignant Neoplasm
Location: Nashville TN, Fairfax VA, Baltimore MD, Houston TX,
Sponsor: NextPoint Therapeutics, Inc.

Sex: All

Age: 19+

Code: NCT07563829

Phase 1, Recruiting

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for
Breast Neoplasms, Neoplasm Metastasis
Location: Nashville TN, Tupelo MS, Newnan GA, Asheville NC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07174336

Phase 3, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

for
Lung Cancer (NSCLC), Prostate Cancer, Esophageal Cancer,
Location: Nashville TN, Orlando FL, Houston TX
Sponsor: Phrontline Biopharma

Sex: All

Age: 18+

Code: NCT07181473

Phase 1, Recruiting

Study in Advanced Solid Tumor Patients

for
Advanced Solid Tumor
Location: Nashville TN, Houston TX, San Antonio TX,
Sponsor: Callio Therapeutics

Sex: All

Age: 18+

Code: NCT07300943

Phase 1, Phase 2, Recruiting

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

for
Lymphoma Diffuse Large B-cell, Leukemia and Lymphoma,
Location: Nashville TN
Sponsor: AvenCell Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07284433

Phase 1, Phase 2, Recruiting